26.4亿元估值背后的长效技术突围。来源|医药研究社特应性皮炎、过敏性哮喘、过敏性鼻炎、荨麻疹这些常见疾病的治疗需求,正在孕育一个庞大的市场——过敏性疾病药物。根据弗若斯特沙利文数据,2019-2023年,全球过敏性疾病药物市场规模由455亿美元增长至618亿美元,复合年增长率为8.0%,预计到2032年将进一步扩大至1222亿美元,2023-2032年的复合年增长率为7.9%。病种具有较高发病率...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.